|
|
Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/812
|
| Title: | Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors |
| Authors: | Kiguba, Ronald
Byakika-Tusiime, Jayne
Karamagi, Charles A. S.
Ssali, Francis
Mugyenyi, Peter
Katabira, Elly |
| Keywords: | Discontinuation of antiretrovirals
Highly Active Antiretroviral Therapy (HAART)
Modification of antiretrovirals
Sub-Saharan Africa
Treatment interruption |
| Issue Date: | 2007 |
| Publisher: | Lippincott Williams & Wilkins |
| Citation: | Kiguba, R., Byakika-Tusiime, J., Karamagi, C. A. S., Ssali, F., Mugyenyi, P. & Katabira, E. (2007). Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors. Journal of Acquired Immune Deficiency Syndrome, 45(2): 218-223. |
| Abstract: | Background: Data on discontinuation and modification of highly active antiretroviral therapy (HAART) are scarce among sub-Saharan African populations. We sought to estimate the prevalence and to identify factors associated with these phenomena in our resource-limited setting.
Methods: Patients were recruited into this cross-sectional study from 2 treatment centers in Kampala, Uganda. Discontinuation and modification were assessed by self-report using semi-structured quantitative and unstructured qualitative interviews. Discontinuation was defined as the simultaneous stopping of all antiretrovirals for at least 1 month, and modification as the changing of at least 1 antiretroviral used in an initial HAART regimen. Factors independently associated with each outcome were assessed using multivariate logistic regression.
Results: Of 686 subjects evaluated, 94 (13.7%) had ever discontinued therapy, whereas 175 (25.5%) had ever modified their regimen. The median CD4 count was 175 (interquartile range: 66–297) cells/mL. Factors associated with discontinuation were HAART experience before starting the current regimen (odds ratio [OR] = 3.70, 95% confidence interval [CI]: 2.13 to 6.25), use of alternative medicines (OR = 2.18, 95% CI: 1.06 to 4.47), hospitalization (OR = 2.36, 95% CI: 1.32 to 4.20), and 1 year or less on HAART (OR = 11.11, 95% CI: 5.00 to 25.00). Modification was associated with more than 3 months’ duration on HAART (OR = 3.13, 95% CI: 1.16 to 8.33) and being unmarried (OR = 1.64, 95% CI: 1.02 to 2.70).
Conclusions: The proportions of discontinuation and modification of antiretroviral therapy (ART) observed in our resource-poor setting pose a challenge to the limited treatment options presently available. Drug cost as a major reason for discontinuation of HAART has major implications for ART programs that charge fees in resource-limited settings. |
| Description: | © 2007. Lippincott Williams & Wilkins.
This article is available from http://journals.lww.com/jaids/toc/2007/06010 |
| URI: | http://journals.lww.com/jaids/pages/default.aspx
http://journals.lww.com/jaids/toc/2007/06010
http://dx.doi.org/10.1097/QAI.0b013e31805d8ae3
http://hdl.handle.net/123456789/812 |
| ISSN: | 1525-4135
1077-9450 (Online) |
| Appears in Collections: | Research Articles (Health-Sciences)
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| Kiguba-Chs-Res.pdf | | 91Kb | Adobe PDF | View/Open |
|
All items in DSpace are protected by copyright, with all rights reserved.
|
